CD95/CD95L interactions and their role in autoimmunity

被引:20
作者
Ricci-Vitiani, L
Conticello, C
Zeuner, A
De Maria, R
机构
[1] Ist Super Sanita, Lab Hematol & Oncol, I-00161 Rome, Italy
[2] Univ Catania, Inst Gen Pathol, Catania, Italy
关键词
apoptosis; diabetes; Fas; organ-specific auto-immunity; thyroiditis;
D O I
10.1023/A:1009668212375
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD95 (Fas/Apo-1) is a broadly expressed death receptor involved in a variety of physiological and pathological apoptotic processes. Since its discovery, defects in CD95/CD95L system have been proposed as major pathogenic factors responsible for impaired immunological tolerance to self antigens and autoimmunity. Later, analysis of altered sensitivity to CD95-induced apoptosis in cells targeted by the immune response has revealed an unexpected role for CD95 and CD95L in organ-specific autoimmunity. CD95 has been shown to be expressed and functional in virtually all cell types that are target of the organ-specific autoimmune response. Here we review some of the major findings concerning the role of CD95 in autoimmunity, in dysfunctions due to increased or decreased CD95-induced apoptosis.
引用
收藏
页码:419 / 424
页数:6
相关论文
共 50 条
  • [41] B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: Roles of B cell CD95, CD95L and bcl-2 expression
    White, CA
    Nguyen, KB
    Pender, MP
    JOURNAL OF AUTOIMMUNITY, 2000, 14 (03) : 195 - 204
  • [42] The influence of CD95L expression on tumor rejection in mice
    Igney, FH
    Behrens, CK
    Krammer, PH
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) : 2811 - 2821
  • [43] Reactive astrocytes upregulate Fas (CD95) and Fas ligand (CD95L) expression but do not undergo programmed cell death during the course of anterograde degeneration
    Bechmann, I
    Lossau, S
    Steiner, B
    Mor, G
    Gimsa, U
    Nitsch, R
    GLIA, 2000, 32 (01) : 25 - 41
  • [44] CD95 Structure, Aggregation and Cell Signaling
    Levoin, Nicolas
    Jean, Mickael
    Legembre, Patrick
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [45] Mycobacterium tuberculosis exploits the CD95/CD95 ligand system of γδ T cells to cause apoptosis
    Manfredi, AA
    Heltai, S
    Rovere, P
    Sciorati, C
    Paolucci, C
    Gelati, G
    Rugarli, C
    Vaiani, R
    Clementi, E
    Ferrarini, M
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (06) : 1798 - 1806
  • [46] CD95/CD95 ligand-mediated counterattack does not block T cell cytotoxicity
    Jekle, A
    Obst, R
    Lang, F
    Rammensee, HG
    Gulbins, E
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 272 (02) : 395 - 399
  • [47] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
    Tolomeo, M
    Dusonchet, L
    Meli, M
    Grimaudo, S
    D'Alessandro, N
    Papoff, G
    Ruberti, G
    Rausa, L
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (09) : 735 - 742
  • [48] The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis
    Manlio Tolomeo
    Luisa Dusonchet
    Maria Meli
    Stefania Grimaudo
    Natale D'Alessandro
    Giuliana Papoff
    Giovina Ruberti
    Luciano Rausa
    Cell Death & Differentiation, 1998, 5 : 735 - 742
  • [49] CD95 expression and apoptosis during pediatric HIV infection: Early upregulation of CD95 expression
    McCloskey, TW
    Oyaizu, N
    Bakshi, S
    Kowalski, R
    Kohn, N
    Pahwa, S
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 87 (01): : 33 - 41
  • [50] Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity
    Shimizu, M
    Fontana, A
    Takeda, Y
    Yoshimoto, T
    Tsubura, A
    Matsuzawa, A
    CELLULAR IMMUNOLOGY, 2001, 207 (01) : 41 - 48